120 related articles for article (PubMed ID: 31150696)
1. Single-cell analysis of cytoskeleton dynamics: From isoelectric focusing to live cell imaging and RNA-seq.
Gozes I; Ivashko-Pachima Y; Kapitansky O; Sayas CL; Iram T
J Neurosci Methods; 2019 Jul; 323():119-124. PubMed ID: 31150696
[TBL] [Abstract][Full Text] [Related]
2. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
[TBL] [Abstract][Full Text] [Related]
3. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.
Oz S; Kapitansky O; Ivashco-Pachima Y; Malishkevich A; Giladi E; Skalka N; Rosin-Arbesfeld R; Mittelman L; Segev O; Hirsch JA; Gozes I
Mol Psychiatry; 2014 Oct; 19(10):1115-24. PubMed ID: 25178163
[TBL] [Abstract][Full Text] [Related]
4. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
Ivashko-Pachima Y; Gozes I
Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
[TBL] [Abstract][Full Text] [Related]
5. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
[TBL] [Abstract][Full Text] [Related]
6. A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome.
Gozes I; Shazman S
Eur J Neurosci; 2023 Jul; 58(2):2641-2652. PubMed ID: 36669790
[TBL] [Abstract][Full Text] [Related]
7. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
Gozes I
Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
[TBL] [Abstract][Full Text] [Related]
8. Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation.
Hadar A; Kapitansky O; Ganaiem M; Sragovich S; Lobyntseva A; Giladi E; Yeheskel A; Avitan A; Vatine GD; Gurwitz D; Ivashko-Pachima Y; Gozes I
Mol Psychiatry; 2021 Nov; 26(11):6550-6561. PubMed ID: 33967268
[TBL] [Abstract][Full Text] [Related]
9. ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.
Malishkevich A; Leyk J; Goldbaum O; Richter-Landsberg C; Gozes I
J Mol Neurosci; 2015 Oct; 57(2):304-13. PubMed ID: 26315608
[TBL] [Abstract][Full Text] [Related]
10. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
Gozes I
Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
[TBL] [Abstract][Full Text] [Related]
11. SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.
Ivashko-Pachima Y; Ganaiem M; Ben-Horin-Hazak I; Lobyntseva A; Bellaiche N; Fischer I; Levy G; Sragovich S; Karmon G; Giladi E; Shazman S; Barak B; Gozes I
Mol Psychiatry; 2022 Aug; 27(8):3316-3327. PubMed ID: 35538192
[TBL] [Abstract][Full Text] [Related]
12. Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.
Hacohen-Kleiman G; Sragovich S; Karmon G; Gao AYL; Grigg I; Pasmanik-Chor M; Le A; Korenková V; McKinney RA; Gozes I
J Clin Invest; 2018 Nov; 128(11):4956-4969. PubMed ID: 30106381
[TBL] [Abstract][Full Text] [Related]
13. Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting.
Kapitansky O; Karmon G; Sragovich S; Hadar A; Shahoha M; Jaljuli I; Bikovski L; Giladi E; Palovics R; Iram T; Gozes I
Cells; 2020 Oct; 9(10):. PubMed ID: 33086621
[TBL] [Abstract][Full Text] [Related]
14. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
Shiryaev N; Pikman R; Giladi E; Gozes I
Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
[TBL] [Abstract][Full Text] [Related]
15. The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.
Gozes I; Divinski I
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S37-41. PubMed ID: 15665412
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
Magen I; Gozes I
Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
[TBL] [Abstract][Full Text] [Related]
17. Tauopathy in the young autistic brain: novel biomarker and therapeutic target.
Grigg I; Ivashko-Pachima Y; Hait TA; Korenková V; Touloumi O; Lagoudaki R; Van Dijck A; Marusic Z; Anicic M; Vukovic J; Kooy RF; Grigoriadis N; Gozes I
Transl Psychiatry; 2020 Jul; 10(1):228. PubMed ID: 32661233
[TBL] [Abstract][Full Text] [Related]
18. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
Ivashko-Pachima Y; Maor-Nof M; Gozes I
PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
[TBL] [Abstract][Full Text] [Related]
19. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
Merenlender-Wagner A; Shemer Z; Touloumi O; Lagoudaki R; Giladi E; Andrieux A; Grigoriadis NC; Gozes I
Autophagy; 2014; 10(12):2324-32. PubMed ID: 25484074
[TBL] [Abstract][Full Text] [Related]
20. The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities.
Oz S; Ivashko-Pachima Y; Gozes I
PLoS One; 2012; 7(12):e51458. PubMed ID: 23272107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
